“ "This is the most valuable aspect of our operations – that we were able to commercialize this cutting-edge technology of quantum dots in the diagnostics field." ”
In Conversation
“ "After working as a scientist for many years, at some point, I started to ask myself: what is the purpose of publishing so many research papers?… ”
“ "I firmly believe that the Chinese healthcare and life sciences industry is poised on the brink of explosive growth. Shenzhen offers the best development opportunities for… ”
“ "We are unique, however, because we not only provide the test results, which are after all just reports, but we can also create a personalised treatment… ”
Many of your counterparts have spoken about the unique operational and strategic challenges China poses to their organizations. How does PAREXEL adapt itself to compete in…
Every “sea turtle” has a different story. What’s yours, and how did you come to found Wincon? I am a “sea turtle” just like other Chinese returnees.…
You are the CEO of GCP CMIC ClinPlus in addition to R&G PharmaStudies, and before that you headed a number of companies as well. Could you…
We’re meeting you just after a conference where you were a keynote speaker. Could you share with us some of your insights from the day’s events?…
Although MicroConstants traces its history back to 1998 in San Diego, you co-founded the China operations in 2007. What’s the story behind how that came about?…
Celgene is a relative newcomer to China. What’s the story behind how the company entered the market, and how did you yourself come to manage the…
We last met with you as the head of Zuellig in 2009. Obviously, a lot has changed since then; from both a sector and corporate point…
Among Big Pharma, Sanofi has a track record of placing a lot of faith in emerging markets – with local production, a large product portfolio, and…
